Cargando…
Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
The incidence and prevalence of chronic kidney disease (CKD) continue to increase worldwide remaining as a major public health burden. CKD eventually progresses to end-stage kidney failure and patients with CKD have high morbidity and mortality. Sirtuin 1 (SIRT1), a NAD+-dependent deacetylases, has...
Autores principales: | Yan, Jiayi, Wang, Jue, He, John Cijiang, Zhong, Yifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251114/ https://www.ncbi.nlm.nih.gov/pubmed/35795148 http://dx.doi.org/10.3389/fendo.2022.917773 |
Ejemplares similares
-
SIRT1 Is a Potential Drug Target for Treatment of Diabetic Kidney Disease
por: Zhong, Yifei, et al.
Publicado: (2018) -
Sirtuin Family and Diabetic Kidney Disease
por: Bian, Che, et al.
Publicado: (2022) -
Sirtuins and Insulin Resistance
por: Zhou, Shuang, et al.
Publicado: (2018) -
Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
por: Wang(a), Jie, et al.
Publicado: (2021) -
Regulation of Adaptive Immune Cells by Sirtuins
por: Warren, Jonathan L., et al.
Publicado: (2019)